期刊文献+

固相萃取-高效液相色谱法测定紫杉醇脂质纳米粒体外释放度 被引量:2

Determination of in Vitro Drug Release of Paclitaxel Lipid Nanoparticles by Solid Phase Extraction-HPLC
原文传递
导出
摘要 目的:建立测定紫杉醇脂质纳米粒体外释放度的方法,考察紫杉醇脂质纳米粒24h的体外释放度。方法:采用固相萃取-高效液相色谱法。样品经C18固相萃取柱萃取,采用Phenomenex luna C18(250mm×4.6mm,5μm)色谱柱分离,流动相为甲醇-水(80:20),流速为1.0mL.min-1,检测波长为227nm。结果:紫杉醇的检测浓度在2~12μg.mL-1范围内与峰面积积分值呈良好线性关系(r=0.9993),紫杉醇脂质纳米粒在水杨酸钠(1mol.L-1)-PBS(pH7.4)中24h累积释放度为104.9%,其释放规律符合一级动力方程。结论:所建方法简便、灵敏,干扰小,可用于体外释放的检测。 OBJECTIVE: To develop a solid phase extraction (SPE)-HPLC method for in vitro drug release of Paclitaxel lipid nanoparticles, and to investigate in vitro drug release of Paclitaxel lipid nanoparticles within 24 h. METHODS: The sample was purified with C18 solid phase extraction columns. The chromatographic analysis was performed on a phenomenex luna C18(250 mm×4.6 mm, 5 μm) column with mobile phase consisted of methanol-water (80:20) at the flow rate of 1.0 mL.min-1. The detection wavelength was set at 227 nm. RESULTS: The linear range of paclitaxel was 2-12 μg.mL-Z(r=0.999 3). The in vitro cumulative release of paclitaxel in 1 mol. L-1 sodium salicylate solution -PH 7.4 PBS reached about 104.9% in 24 h. The profile was described by first-class equation. CONCLUSION: The method is simple, sensitive and little interference, and it is suitable for the determination of in vitro drug release of sample.
出处 《中国药房》 CAS CSCD 2012年第7期608-610,共3页 China Pharmacy
关键词 紫杉醇 固相萃取 高效液相色谱法 体外释放 Paclitaxel Solid phase extraction HPLC In vitro drug release
  • 相关文献

参考文献9

  • 1Loprevitr M, Roberto EF, Alessandra DC, et al. Interaction between novel anticancer and radia-ton inno-small cell lung cancer cell lines[J]. Lung Cancer, 2001,33 (1) : 27.
  • 2van Zuylen L, Verweij J, Sparreboom A. Role of formulation vehicles in taxane pharmacology[J]. Invest New Drugs, 2001,19(2) : 125.
  • 3Kim SC, Yoon HJ, Lee JW, et al. Investigation of the release behavior of DEHP from infusion sets by paclitaxel-loaded polymeric micelles[J]. Int J Pharm, 2005,293 (1-2) :303.
  • 4Donyai P, Sewell GJ. Physicaland chemical stability ofpaclitaxel infusions in different container types[J]. J Oncol Pharm Pract,2006,12(4) :211.
  • 5张恩娟,陈琳,曹健.紫杉醇注射液配套输液器中邻苯二甲酸二辛酯的溶出性考察[J].中国药房,2008,19(9):698-700. 被引量:31
  • 6Sagar RM, Amol BD, Sachin P, et al. Nanoparticles: emerging carders for drug delivery[J]. Saudi Pharmaceutical Journal,2011,19(3) : 129.
  • 7Huh KM, Min HS, Lee SC, et al. A new hydrotropic block copolymermicelle system for aqueous solubilization of paclitaxel[J]. J Control Release, 2008,126 (2) : 122.
  • 8Cho YW, Lee J, Lee SC, et al. Hydrotropic agents for study of invitro paclitaxel release from polymeric micelles [J]. JControlRelease,2004, 97(2) :249.
  • 9林巧平,郭仁平,王青松,王冬春,刘春晖,许向阳.注射用多西他赛脂质体的制备、体外释放及细胞毒作用[J].中国药科大学学报,2008,39(5):417-421. 被引量:12

二级参考文献16

  • 1陆红霞,徐丛剑,李斌.紫杉醇剂型、临床用药方式及联合用药的研究进展[J].国外医学(药学分册),2005,32(2):73-77. 被引量:11
  • 2奚廷斐,王春仁.邻苯二甲酸二异辛酯增塑聚氯乙烯医疗器械的安全性评价[J].中国医疗器械信息,2005,11(2):27-30. 被引量:28
  • 3宋晓峰,魏光辉.医用塑料增塑剂DEHP安全性研究及对策[J].国外医学(卫生学分册),2005,32(6):358-361. 被引量:37
  • 4Kim JH, Yun J, Sohng JK, et al .Di( 2 - ethylhexyl) phthalate leached from medical PVC devices serves as a substrate and inhibitor for the P - glycoprotein[J ]. Environ Toxicol Pharmacol , 2007,23(3) : 272.
  • 5US Food and Drug Administration:safety assessment of di(2 - ethylhexyl) phthalate(DEHP) released from PVC medical devices[R]. 2002.
  • 6Nour kayali, FernandoG,Tamayo .Determination of diethylhexyl phtalate in water by solid phase microextraction coupled to high performance liquid chromatography [J ]. Talanta ,2006,69(5) :1 095.
  • 7Herbst, RS, Khuri FR. Mode of action of docetaxel-a basis for combination with novel anticancer agents [ J ]. Cancer Treat Rev,2003,29(5 ) :407 -415.
  • 8Engels FK, Mathot RA, Verweij J. Alternative drug formulations of doeetaxel : a review [ J ]. Anticancer Drugs, 2007,18 ( 2 ) : 95 - 103.
  • 9Baker SD, Zhao M, He P, et al. Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometry[ J]. Anal Biochem ,2004,324 ( 2 ) :276 - 284.
  • 10陆彬(Lu B).药物新剂型与新技术[M].第2版.北京:人民卫生出版社,2005:149.

共引文献41

同被引文献26

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部